Dr. Arne van Schanke joined Certara (formerly Quantitative Solutions) in July 2014 as a quantitative pharmacologist. He has worked in the MSD’s Quantitative Pharmacokinetics and Pharmacology department and served as head of the biotransformation group at Organon and Schering-Plough, adding to nine years in pharmaceutical research and development. Arne’s expertise in clinical pharmacokinetics and pharmacodynamics, drug-drug interactions and therapeutic areas as oncology, virology and fertility has matured in discovery to Phase 3 development teams. His scientific oversight was trained in CTD authoring, due diligence evaluations, development strategy discussions and correspondence with regulatory authorities.
Arne received his Master’s degree in Environmental Health from Wageningen University, The Netherlands and his PhD degree in Veterinary Medicine from the Utrecht University, The Netherlands. He fulfilled post-doctoral positions at the University Medical Centers of Utrecht and Leiden, The Netherlands. Arne is married and enjoys all-terrain biking and visiting his sons’ soccer games.